varenicline has been researched along with AIDS Seroconversion in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cohen, J; Cui, Q; Elston, D; McFarland, N; McIvor, A; Quan, C; Robinson, L; Smaill, F; Smieja, M; Thabane, L; Zeidler, J | 1 |
1 trial(s) available for varenicline and AIDS Seroconversion
Article | Year |
---|---|
Safety and tolerability of varenicline tartrate (Champix(®)/Chantix(®)) for smoking cessation in HIV-infected subjects: a pilot open-label study.
Topics: Adult; Affect; Benzazepines; Cotinine; Dreams; Female; Follow-Up Studies; HIV Seropositivity; Humans; Indicators and Reagents; Male; Middle Aged; Nausea; Nicotinic Agonists; Ontario; Pilot Projects; Prevalence; Quinoxalines; Sleep Initiation and Maintenance Disorders; Smoking; Smoking Cessation; Treatment Outcome; Varenicline | 2012 |